| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3361496 | International Journal of Antimicrobial Agents | 2006 | 5 Pages |
Abstract
This review will summarise the relevant pathophysiology of sepsis, the rationale for treatment with recombinant human activated protein C and the evidence for and against its use, and will provide evidence-based recommendations for its administration.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Martin Hughes,